Download the latest data exploring Microbiome Drug Development in Asia.
Covered in the Infographic:
- An overview of the Asian Microbiome market and it’s significance within the wider global space
- Analysis of the 160+ Asian companies tracked on Beacon Microbiome by company type and size, along with a look at funding type and potential deal value
- A deep dive into the most prominent disease targets and therapeutic classes in the Asian market
To learn more about the infographic and how Beacon Microbiome can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.
Find out more
Speak with our Team of Experts
Our dedicated team is on hand to showcase how Beacon can help you find the answers to your microbiome-related questions.
About Beacon
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements.
